ReviewFrontiers in pharmacology2026
Point-of-care testing reduces antibiotic prescribing for adults with community-acquired pneumonia: a systematic review and meta-analysis.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate the impact of point-of-care testing (POCT) on antibiotic prescribing and clinical outcomes in adult patients with community-acquired pneumonia (CAP) through a systematic review and meta-analysis. Methods: Web of Science, Scopus, Embase, PubMed, and Cochrane Library were searched for randomized controlled trials (RCTs). The final search was conducted on June 2025. Outcomes included both antibiotic-related and clinical outcomes. The meta-analysis was performed using Review Manager. The study was registered with PROSPERO (CRD420251035572). Results: Nine RCTs involving 2,899 participants were included. POCT significantly reduced the proportion of adult CAP patients receiving antibiotic prescriptions by 10% (RD = -0.10; 95% CI: -0.15 to -0.05, Conclusion: POCT may reduce antibiotic exposure in patients with CAP without compromising clinical outcomes. As diagnostic innovation plays an increasingly important role in combating antimicrobial resistance, POCT should be used selectively as an adjunct to clinical judgment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.